Emflaza
Deflazacort
Package | Per pill | Price | Savings | Order |
---|---|---|---|---|
120 tablet
Free AirMail shipping
Hot
|
₩ 6314.77
|
₩ 757772.42₩ 6314.77
|
₩ 137513.75
|
|
90 tablet
Free AirMail shipping
Hot
|
₩ 6659.05
|
₩ 599314.69₩ 6659.05
|
₩ 72149.94
|
|
60 tablet
Free AirMail shipping
Hot
|
₩ 6888.32
|
₩ 413299.10₩ 6888.32
|
₩ 34343.99
|
|
36 tablet
Free AirMail shipping
Hot
|
₩ 7270.30
|
₩ 261730.83₩ 7270.30
|
₩ 6855.02
|
|
24 tablet
|
₩ 7460.72
|
₩ 179057.23₩ 7460.72
|
|
Package | Per pill | Price | Savings | Order |
---|---|---|---|---|
90 tablet
Free AirMail shipping
Hot
|
₩ 7654.20
|
₩ 688877.76₩ 7654.20
|
₩ 137599.87
|
|
60 tablet
Free AirMail shipping
Hot
|
₩ 8266.21
|
₩ 495972.69₩ 8266.21
|
₩ 55012.39
|
|
36 tablet
Free AirMail shipping
Hot
|
₩ 8801.29
|
₩ 316846.56₩ 8801.29
|
₩ 13744.49
|
|
24 tablet
Free AirMail shipping
Hot
|
₩ 9183.08
|
₩ 220394.03₩ 9183.08
|
|
Deflazacort tablets
What is this medicine?
Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
What should I tell my health care providers before I take this medicine?
They need to know if you have any of these conditions:
- Hypersensitivity to deflazacort;
- Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
- Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
- Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
- Gastrointestinal Perforation: GI disorders;
- Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
- Effects on Bones: decreases in bone mineral density;
- Serious Skin Rashes;
- Ophthalmic Effects: May include cataracts, infections, and glaucoma;
- Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.
How should I use this medicine?
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..
What may interact with this medicine?
- Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
- Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.
What side effects may I notice from this medicine?
The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.